reference/14793712

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14793712

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	9369
issn	1949-2553
issueIdentifier	11
pageRange	9355-9369
publicationName	Oncotarget
startingPage	9355
bibliographicCitation	Deng R, Zhao X, Qu Y, Chen C, Zhu C, Zhang H, Yuan H, Jin H, Liu X, Wang Y, Chen Q, Huang J, Yu J. Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development. Oncotarget. 2015 Apr 20;6(11):9355–69. PMID: 25823821; PMCID: PMC4496222.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00e1f613d9385faa3d1e8c1ef052a1d0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_97346128bb6a9d037cbaed577bf43727 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_63ce814e6a5721740fcaf6a9e8c9f29b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_240bb84dacd535e8201bb86cea02d98f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfb58fd30b8ba99a551259947cab86d4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b0968966c6bf5509a90f6b8495fd3eec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ec58a3a81be10a28b49d8757198ab8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0e9e7d6a5a67d3673965f87760804f3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a7fe903acf4722862b03b83d2cbad087 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ee782b70a0d45ca3cbe6691153be9285 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c0403abecb5b8299758876c92db8493a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0eacae3ea31cfa15117a61bde3eae773 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa26c6e2a3719acb7b927bd8352b9961
date	2015-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC4496222 https://doi.org/10.18632/oncotarget.3323 https://pubmed.ncbi.nlm.nih.gov/25823821
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/37803 https://portal.issn.org/resource/ISSN/1949-2553
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Shp2 SUMOylation promotes ERK activation and hepatocellular carcinoma development
discusses	http://id.nlm.nih.gov/mesh/M0382717 http://id.nlm.nih.gov/mesh/M0027004
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D006528Q000378 http://id.nlm.nih.gov/mesh/D008113Q000378 http://id.nlm.nih.gov/mesh/D054592Q000378 http://id.nlm.nih.gov/mesh/D048049Q000378 http://id.nlm.nih.gov/mesh/D058207
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D006367 http://id.nlm.nih.gov/mesh/D008113Q000473 http://id.nlm.nih.gov/mesh/D054592Q000235 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D002471Q000378 http://id.nlm.nih.gov/mesh/D014407 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D051379 http://id.nlm.nih.gov/mesh/D004789 http://id.nlm.nih.gov/mesh/D006528Q000473 http://id.nlm.nih.gov/mesh/D056945 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D057809 http://id.nlm.nih.gov/mesh/D006801
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11431 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_966b69495aff24dd4bc4208192414e49 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fa2ab9fe838f009771a4a21a0ae3d1aa http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_89d708279e197fec68596fc46bc48c90 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7998 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_92eac2f85bf0b50ce8e5339aba5e54a9 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5962 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_993c88b13f18d552189e047b2e4f07c2 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0907de42401b965fd4aefb807d0b2038 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_0943bfb20a0e8ebccd479b74c7b652df http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_be0f121e3dfac777029046de48f568af http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_7478b462389af17ec2f7980a4e0b428f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5781

Total number of triples: 67.